Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEOLBC: Ribociclib + Letrozole vs Chemotherapy in Luminal Breast Cancer
NCT03283384Phase 2Active, not recruiting
- Sponsor
- Borstkanker Onderzoek Groep
- Start
- Jun 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ribociclib in breast cancer, sponsored by Borstkanker Onderzoek Groep. Started Jun 2019; status: active, not recruiting.
02
Drugs
ribociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03283384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03283384.